Physician Assistant Program year 2025 Reported 2021–2025 Source: CMS Open Payments, 2026 publication

Matthew Dincher

Physician Assistant, Surgical Beckley, WV Physician Assistant

NPI 1992083992 CMS profile 11188173

94 Brookshire Ln, Beckley, WV 25801

Open in the dashboard

General payments

$6,265

491 records reported · program years 2021–2025

Research payments

$0

Paid to them · None reported · program years 2021–2025

Ownership & investment interest

$0

None reported

Through program year 2025, Matthew Dincher of Beckley, WV is reported in the CMS Open Payments database as having received $6,265 across 491 general payments and $0 in research payments paid to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.

General payments for this record sit in the 96th percentile of Physician Assistant, Surgical profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

5 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $2,225 157
2024 General $1,148 88
2023 General $1,211 125
2022 General $687 54
2021 General $994 67

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Matthew Dincher
  • Physician Assistant, Surgical median
  • Middle half of Physician Assistant, Surgical
  • National median

In program year 2025, general payments to Matthew Dincher were reported at $2,225. Among 8,152 Physician Assistant, Surgical profiles paid that year, the median was $146 and the middle half received between $51 and $385.

Show as a table
Year Matthew Dincher Physician Assistant, Surgical median Middle half National median
2019 $0 — — $163
2020 $0 — — $114
2021 $994 $111 $36–$285 $132
2022 $687 $126 $44–$350 $149
2023 $1,211 $137 $47–$355 $160
2024 $1,148 $146 $49–$384 $164
2025 $2,225 $146 $51–$385 $169

Breakdown

Who paid General payments · program years 2021–2025
  1. AbbVie, Inc. $1,730 172 payments
  2. UCB, Inc. $1,491 142 payments
  3. Janssen Biotech, Inc. $1,246 94 payments
  4. Sun Pharmaceutical Industries Inc. $487 18 payments
  5. Lilly USA, LLC $277 13 payments
  6. Regeneron Healthcare Solutions, Inc. $267 9 payments
  7. Galderma Laboratories, L.P. $214 18 payments
  8. E.R. Squibb & Sons, L.L.C. $109 5 payments
  9. Sanofi-Aventis U.S. LLC $100 1 payment
  10. Pfizer Inc. $93 5 payments
  11. Other $253 14 payments

Every payment, record by record

What the payments were for General payments · program years 2021–2025
  1. Food and Beverage $5,526 481 payments
  2. Education $740 10 payments
Products named General payments · program years 2021–2025
  1. TREMFYA $1,194 90 payments
  2. Bimzelx $777 49 payments
  3. SKYRIZI Immunology $736 75 payments
  4. Cimzia $714 93 payments
  5. SKYRIZI Immunology $487 40 payments
  6. RINVOQ $438 51 payments
  7. TALTZ $277 13 payments
  8. EBGLYSS $201 9 payments
  9. ILUMYA $199 13 payments
  10. NEMLUVIO $182 16 payments
  11. Other $1,094 55 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Prescribing to Medicare patients

Part D · data year 2024 · 19 drugs

Part D claims

1,320

Median for Physician Assistant: 241

Drug cost

$487,928

Median for Physician Assistant: $4,110

Branded share of claims

10.5%

Median for Physician Assistant: 19.6%

Drugs this doctor was counted under in Medicare Part D 2024, by drug cost
Drug Type Relative to their largest Claims Drug cost
Dupixent Syringe Dupilumab Brand 79 $320,559
Rinvoq Upadacitinib Brand 21 $140,663
Triamcinolone Acetonide Generic 371 $5,993
Clobetasol Propionate Generic 107 $4,940
Ketoconazole Generic 271 $4,306
Clindamycin Phosphate Generic 70 $3,426
Fluorouracil Generic 28 $2,408
Tretinoin Generic 15 $1,440
Dapsone Generic 20 $988
Minocycline Hcl Generic 51 $644

The 10 drugs with the highest cost, of 19 counted.

Drug cost is what was paid for the drugs at the pharmacy — by Medicare, the patient and others — and is not money to the prescriber. Medicare Part D only: drugs dispensed to Medicare beneficiaries. A drug with fewer than 11 claims for this prescriber is not published, so a missing drug does not mean zero. The medians are for the 114,276 Part D prescribers listed as Physician Assistant; they describe a distribution and say nothing about conduct.

Billing to Medicare

Part B · data year 2024 · 62 billing codes

Paid by Medicare

$128,520

Of which drugs: $6,964

Medicare patients

504

Average age 72

Services billed

2,881

253 women, 251 men among their patients

Share of this provider's Medicare patients with each condition
Condition among their Medicare patients Relative to the most common Share of patients
High blood pressure 75%
Arthritis 49%
Diabetes 35%
Ischemic heart disease 33%
Chronic kidney disease 22%
Depression 22%
COPD 21%
Atrial fibrillation 20%
Drugs given in the clinic that this provider billed Medicare Part B for
Drug given in the clinic Where Patients Services Paid by Medicare
Injection, betamethasone acetate 3 mg and betamethasone sodium phosphate 3 mg J0702 Office 18 68 $319
Injection, triamcinolone acetonide, not otherwise specified, 10 mg J3301 Office 19 133 $85

Medicare Part B only: services billed to Medicare. Rows covering fewer than 11 beneficiaries are not published. Only drugs given in the clinic are itemised here; the rest of what this provider billed is in the total above.

Payments and prescribing

First 5 of 10 products · payments 2024

Two separate records. The payments come from Open Payments and the claims from Medicare. They are set side by side because they name the same product; they do not show that a payment affected a prescription.

Products this doctor was paid in connection with in 2024, beside Medicare claims for the same product
Product Paid by Related payments Part D claims Part B services
Bimzelx
  • UCB, Inc. $362
$362 — —
TREMFYA
  • Janssen Biotech, Inc. $255
$255 — —
SKYRIZI
  • AbbVie, Inc. $154
$154 — —
RINVOQ
  • AbbVie, Inc. $109
$109 21 —
SOTYKTU
  • E.R. Squibb & Sons, L.L.C. $30
$30 — —

A dash means Medicare published no figure for this doctor and product — fewer than 11 claims, or the product is not covered under that part — which is not the same as none. Payments are general payments only; one that names several products is split evenly between them, so an amount is payments related to the product, not money paid for it.

See all 10 in the dashboard with a free account

Records

491 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Physician Assistant, Surgical in West Virginia

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record